Men, especially after the age of 50, have long been told they need to be screened regularly for the dreaded disease of prostate cancer with a prostate-specific antigen (PSA) test. The reason? Because if caught early, this common cancer can be treated before it supposedly kills. Sound familiar? If you think these are the facts about prostate cancer, it’s time to learn the real truth.
None other than a large mainstream medical group, the American College of Physicians (ACP), has just released a statement changing recommendations for prostate cancer screening. And while the official statement emphasizes that the ACP is saying patients need to be better informed and work with doctors to decide on screening, let’s take a look at the far more important facts revealed in the announcement. (more…)
The British Journal of Nutrition reported in November 2012 that fatty acids and coenzyme Q10 (CoQ10) alter serum levels of prostate specific antigen (PSA). PSA is a protein produced by prostate cells. Elevated levels of PSA are associated with prostate issues such as prostate cancer, benign prostatic hyperplasia (BPH) and acute bacterial prostatitis.
The investigators evaluated 504 healthy men with serum PSA level of 2.5 ng/ml or lower. The subjects received daily supplementation with:
1. Omega-3 fatty acids, including 1.12 grams of eicosapentaenoic acid (EPA) and 0.72 grams of docosahexaenoic acid (DHA) per capsule, (more…)
For decades now, the standard treatment for prostate cancer has been surgery — but that standard’s about to change in a big way.
A growing number of studies have proven that those surgeries don’t save or even extend lives in prostate cancer patients. And now, a major new study shows again that the best treatment for the disease may be nothing at all. (more…)
The verdict is in — PSA tests for prostate cancer are unreliable, and do not offer men any tangible benefit in lifespan or quality of life. These are the conclusions of the U.S. Preventive Services Task Force (PSTF), which found that many more men are injured by PSA tests than are helped by it.
PSA, also known as prostate specific antigen, is a biological marker that doctors and healthcare practitioners often use to detect the presence of a potential prostate tumor. Since PSA levels in the blood are known to climb in response to prostate tumors, it is commonly thought that early detection can help in mitigating the cancer. (more…)
Study Shows No Benefit from Surgery in Prostate Cancer
We can put another nail in the coffin of mainstream medicine’s claim to being scientific and evidence based. The standard treatment for prostate cancer is rapid and drastic surgical removal of the prostate. It’s been done for years on the presumption that removal eliminates the cancer. There has never, though, been any evidence documenting any truth that it’s effective—but surgeons have been pulling out their scalpels without scruple, leaving a swath of impotent and incontinent men behind. (more…)
Extended follow-up shows reduced risk of death from prostate cancer, but not overall risk of death
WEDNESDAY, March 14 (HealthDay News) — Screening men for prostate-specific antigen (PSA) levels significantly reduces their risk of death from prostate cancer, but not their overall risk of death, according to a study in the March 15 issue of the New England Journal of Medicine.
Fritz H. Schröder, M.D., from the Erasmus University Medical Center in Rotterdam, Netherlands, and colleagues re-analyzed mortality after an additional two years of follow-up in a European study of 162,388 men (aged 55 to 69 years) who had been randomized to screening for PSA levels or no screening. (more…)
The best way to protect your prostate is to keep it far away from doctors who want to screen it — and even further from the surgeons who make a living off prostate cancer procedures.
Not long ago, this was considered a rogue approach.
Today, it’s mainstream science — and another study confirms again that all the screenings in the world don’t save lives.
Simply put, the government-funded study of 76,000 men who were tracked for 13 years finds that annual PSA tests don’t make a bit of difference in determining who lives and who dies. (more…)
For many years, the mainstay of prostate cancer diagnosis has been the PSA (prostate-specific antigen) test, which measures the levels of a protein produced by the cells of the prostate gland. However, newer studies have shown the PSA test is not as accurate as originally assumed. (more…)
A hardhat is better protection against prostate cancer than the PSA test.
Men, do you want to lessen your risk of dying from prostate cancer? If so, then take heed of a new study showing that the risk of death from prostate cancer increases in men who have the PSA screening test. (more…)
A common medical myth is that Testosterone is somehow causative of prostate cancer. This is incorrect, as we will see below. Rather than elevated Testosterone being associated with prostate cancer, it is LOW testosterone that is associated with aggressive prostate cancer with poor outcome. Indeed, lower testosterone has been found to be associated with increased all cause mortality in males in the EPIC study. (more…)